Remeditex Ventures LLC, 10% Owner at Menlo Therapeutics, Inc. (MNLO), bought 102,650 shares at $17.00 ($1.7M) on 2018-01-25, disclosed to the SEC on 2018-01-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.00 | 100,000 | $1.7M | 100.0% |
| 2 | $0.00 | 2,650 | $0 | 0.0% |
| Total | $16.56 avg | 102,650 | $1.7M | 100% |